Last reviewed · How we verify
NCT06904976
Nature-Focused Mindfulness and Spiritual Well-being Among Adults with Moderate Prolonged Grief Symptoms
NA trial testing Nature-focused mindfulness in Grief in 230 participants. Not yet recruiting.
9 September 2025
Quick facts
| Lead sponsor | University of Twente |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 230 |
| Start date | 24 March 2025 |
| Primary completion | 9 September 2025 |
| Estimated completion | 9 September 2025 |
Drugs / interventions tested
- Nature-focused mindfulness
- Noticing-nature
Conditions studied
- Grief — all drugs for Grief →
- Spiritual Wellbeing — all drugs for Spiritual Wellbeing →
Sponsor
University of Twente
Who can join
18 and older, any sex, with Grief or Spiritual Wellbeing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this randomized controlled trial is to evaluate whether a nature-focused mindfulness intervention can enhance spiritual well-being and reduce grief symptoms among adults with moderate prolonged grief symptoms. The main questions it aims to answer are: Does a nature-focused mindfulness intervention improve spiritual well-being compared to an active control condition (noticing nature) and a waitlist control condition? Does a nature-focused mindfulness intervention reduce grief severity and improve mental well-being, nature connectedness, selflessness, ability to adapt, personal recovery, and elevation compared to control conditions? How do spiritual well-being, ability to adapt, nature connectedness, selflessness, grief reactions, and positive/negative affect change during the intervention period? Researchers will compare a nature-focused mindfulness intervention to both a noticing-nature active control group and a waitlist control group to isolate mindfulness-specific effects from possible general nature exposure benefits. Participants will: Complete baseline, post-intervention, and follow-up assessments (at one and three months) Engage in either 10 sessions of nature-focused mindfulness practice or noticing nature activities over a two-week period (intervention and active control groups) Provide daily diary responses about their experiences throughout the 14-day intervention period
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06904976
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Grief
Currently open trials in the same condition.
- NCT07009795 — Rise & Renew: Supporting Well-Being in Black Women After the Loss of a Loved One · NA · active not recruiting
- NCT06828276 — Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants · NA · recruiting
- NCT06981598 — Prevention of Psychological Health Problems Via Integrated Operational Support · NA · recruiting
- NCT05624879 — Accelerated Resolution Therapy for Early Maladaptive Grief · NA · recruiting
- NCT05696704 — Telehealth to Reduce Mental Health in Family Caregivers · NA · recruiting
Other University of Twente trials
Trials by the same sponsor.
- NCT07475260 — SVF-Treo Study: Influence of Cardiac and Respiratory Pulsatility Deformation · not yet recruiting
- NCT06658340 — Feasibility of a Well-being Promotion Self-management Intervention in Post-COVID-19 Patients · NA · completed
- NCT06365736 — The Effect of a Contemplative Nature-based Intervention on Spiritual Well-being · NA · completed
- NCT06312735 — VR for Patients With Chronic Pain (Wait & Work) · NA · completed
- NCT05791760 — The Effectiveness of CFT for Reducing Self-criticism in Patients with Complex PTSD: a Single-case Experimental Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06904976 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Twente
- Last refreshed: 1 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06904976.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing